Important information.

Your IP address belongs to the address group of Russia. We inform you that starting from June 1, 2020, new clients from Russia are not registered. The company does not stop serving clients registered earlier. The change will affect the payments of the agents’ remuneration too. All registrations from June 1, 2020, for clients who are residents of the Russian Federation, will not be counted in the calculation of the agents’ remuneration. If you are a resident of Russia, take into account the fact of regulation of the activities of CFD dealers in the jurisdiction of the resident. In this regard, we inform that the company does not conduct advertising activities on the territory of Russia, has no registered offices under the Bulltraders brand,, or the name BT Technologies Ltd. BT Technologies Limited is an international company registered in the territory of the state of Saint Vincent and the Grenadines. By clicking on the "Continue" button, you accept the presence of the company in a foreign jurisdiction, confirm that you are a user who has reached the age of majority, and agree that the company has taken the necessary measures to provide this information to you.

Please accept our apologies. With best regards,

The week started with solid gains, unaffected by continued concerns about the pace of economic growth in light of the recent surge in coronavirus infections and uncertainty over the future of the Federal Reserve's stimulus.

Market participants were actively buying up the fallen shares. The market was also supported by the announcement that the Food and Drug Administration (FDA) issued full approval for a COVID-19 vaccine developed by Pfizer (PFE) / BioNTech (BNTX). This is the first full regulatory approval for a COVID-19 vaccine (Pfizer / BioNTech received FDA approval for emergency use late last year). In addition, the July data on US existing home sales exceeded investor expectations. The report from the National Association of Realtors showed that sales of existing homes in July rose 2.0% to a seasonally adjusted annual rate of 5.99 million units, compared with an upwardly revised rate of 5.87 million units in June.

The growth continued on Tuesday, but its pace slowed down. Market participants continued to play back the news of the full approval of the Pfizer (PFE) / BioNTech (BNTX) vaccine. Investors' hopes for a faster vaccination rate and a quick economic recovery have boosted the stock and oil markets. In addition, the Institute for Health Metrics and Evaluation (IHME) predictive model suggested that a peak in the incidence of coronavirus in the United States could already be reached. Market participants also drew attention to a report from the US Department of Commerce, which showed that US new home sales rose in July for the first time in four months, thanks in part to additional stocks and an indication of still robust underlying demand. According to the report, new single-family home purchases rose 1.0% to 708,000 year on year after an upwardly revised 701,000 in June. Experts expected the figure to be 700,000.

The next day the growth continued, but its pace was restrained by investor caution ahead of the key event of the week - the annual Federal Reserve Symposium in Jackson Hole. The theme of the symposium is "Macroeconomic Policy in an Uneven Economy". Earlier this month, several Fed policymakers expressed the view that it would be advisable for the US central bank to begin cutting back on asset purchases as early as the fourth quarter, but several others stressed that more evidence of recovery is needed before the process can begin, especially on labor market. Market participants also studied July data on durable goods orders in the US and several quarterly reports from the corporate segment.

On Thursday trading ended in negative territory. Market sentiment was also undermined by reports of an explosion near the Kabul airport in Afghanistan. Investors analyzed July data on US GDP and claims for unemployment benefits and several quarterly reports of the corporate segment. Commerce Department report showed that the US economy grew slightly faster than originally estimated in the second quarter. According to the ministry's second estimate, US GDP increased 6.6% year-on-year between April and June. This was up from the 6.5% growth rate reported in July. Economists expected second-quarter GDP growth to rise to 6.7%. The economy grew 6.3% in the first quarter and recouped the huge losses incurred during the two-month COVID-19 recession. The data released by the Department of Labor showed that in the week ending August 21, US initial jobless claims rose to 353,000, up 4,000 from the previous week's revised 349,000. Economists expected that the number of applications for unemployment benefits will rise to 350,000 from 348,000 originally announced the previous week.

The week ended with a noticeable increase. The market reacted to statements by Fed Chairman Jerome Powell, which signaled that the US central bank was in no hurry to wind down stimulus. Powell’s speech suggests that the emergence of the delta strain of coronavirus poses additional risks and this may delay the start of phasing out emergency support programs this year. In addition, the chairman of the US central bank signaled that the Fed is in no hurry to raise interest rates.

Company news

11.03.2021 Server problem Read more ...
15.01.2021 Changes in entrance to mobile trading platform Read more ...
18.12.2020 Broker's identification in a mobile platform. Read more ...
18.12.2020 Changes in the schedule of trading sessions in connection with the celebration of the Catholic Christmas. Read more ...
18.12.2020 Happy Xmas and Happy new year! Read more ...
Show all

Expert view

06.09.2021 Technological sector sale Read more ...
06.09.2021 New OPEC+ summit Read more ...
30.08.2021 Rally at the US stock market Read more ...
30.08.2021 Oil quotes to recover after fall Read more ...
22.08.2021 US stock market to analyze corporate reports Read more ...
Show all


Our services include products that are traded on margin and carry a risk that you can lose more than your initial deposit. The products may not be suitable for everyone - please ensure you fully understand the risks involved. There is a high level of risk involved with trading leveraged products such as forex and CFDs. You should not risk more than you can afford to lose, it is possible that you may lose more than your initial investment. You should not trade unless you fully understand the true extent of your exposure to the risk of loss. When trading, you must always take into consideration your level of experience. It is the responsibility of the Client to ensure that the Client can accept the Services and/or enter into the Transactions in the country in which the Client is resident. If the risks involved seem unclear to you, please seek independent advice.